Camber Capital Management LP Sage Therapeutics, Inc. Transaction History

Camber Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$32.2 - $43.61 $22.5 Million - $30.5 Million	700,000 New	700,000 $26.7 Million
Q3 2020 Nov 16, 2020	SELL	$41.13 - $62.45 $21.6 Million - $32.8 Million	-525,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$25.95 - $43.15 $13.6 Million - $22.7 Million	525,000 New	525,000 $21.8 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.